You can access the annual and quarterly cash flow statements of Insight Molecular Diagnostics Ord Shs to evaluate its financial soundness and stability.
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q3
Operating cash flows (indirect method)
Cash flow from continuing operating activities
---4.50M
Net income from continuing operations
---10.85M
Operating gains losses
--584.00K
Other non-cash items
--208.00K
Change in working capital
--1.66M
-Change in receivables
--254.00K
-Change in inventory
--222.00K
-Change in prepaid expenses
--65.00K
-Change in payables and accrued expense
--1.18M
Cash from non-recurring investing activities
Cash from operating activities
---4.50M
Investing cash flow
Net cash from continuing investing activities
--1.05M
Capital expenditures
--1.05M
Net cash flow from disposal of fixed assets
--1.05M
Cash from non-current investing activities
Net cash flow from investing activities
---1.05M
Financing cash flow
Cash flow from continuous financing activities
---120.00K
Net cash flow from debt Issuance/repayment
---332.00K
Net cash flow from common stock issuance/repurchase
--0.00
Net cash flow from preferred stock issuance/repurchase
--0.00
Net cash flow from other financing activities
--212.00K
Net cash from non-recurrent financing activities
Net cash from financing activities
---120.00K
Net cash flow
Beginning cash balance
--25.99M
Current period cash flow changes
---5.78M
Effect of exchange rate changes
---105.00K
Ending cash balance
--20.21M
Free cash flow
---5.55M
Currency unit
USD
Audit opinions
--
FAQs
What is the cash flow statement?
This report tracks the movement of cash into and out of the business, covering operating, investing, and financing activities. It highlights how well the company manages cash to support growth and meet its obligations.